Co-administration of apigenin with doxorubicin enhances anti-migration and antiproliferative effects via PI3K/PTEN/AKT pathway in prostate cancer cells.

Ayyildiz, A; Koc, H; Turkekul, K; Erdogan, S

Ayyildiz, A; Koc, H; Turkekul, K; Erdogan, S.

Affiliation

Ayyildiz A; Trakya University, Balkan Campus, Edirne 22030, Turkey.
Koc H; Trakya University, Balkan Campus, Edirne 22030, Turkey.
Turkekul K; Trakya University, Balkan Campus, Edirne 22030, Turkey.
Erdogan S; Trakya University, Balkan Campus, Edirne 22030, Turkey.

Exp Oncol ; 43(2): 125-134, 2021 06.

Article de En | MEDLINE | ID: mdl-34190523

Sujet(s)

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links

Collection: 01-internacional Base de données: MEDLINE Sujet principal: Transduction du signal / Protocoles de polychimiothérapie antinéoplasique / Mouvement cellulaire / Prolifération cellulaire / Tumeurs prostatiques résistantes à la castration Limites: Humans / Male Langue: En Journal: Exp Oncol Sujet du journal: NEOPLASIAS Année: 2021 Type de document: Article Pays d'affiliation: Turquie Pays de publication: Ukraine

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links